Search by Drug Name or NDC
NDC 24338-0230-12 Nymalize 30 mg/5mL Details
Nymalize 30 mg/5mL
Nymalize is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Azurity Pharmaceuticals, Inc.. The primary component is NIMODIPINE.
MedlinePlus Drug Summary
Nimodipine is used to decrease brain damage that may be caused by a subarachnoid hemorrhage (bleeding in the space surrounding the brain that occurs when a weakened blood vessel in the brain bursts). Nimodipine is in a class of medications called calcium channel blockers. It works by relaxing blood vessels in the brain to allow more blood to flow to damaged areas.
Related Packages: 24338-0230-12Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Nimodipine
Product Information
NDC | 24338-0230 |
---|---|
Product ID | 24338-230_8c3aba10-0b86-4b03-8952-adc2a2b950b4 |
Associated GPIs | 34000022002054 |
GCN Sequence Number | 080991 |
GCN Sequence Number Description | nimodipine SYRINGE 30 MG/5 ML ORAL |
HIC3 | A9A |
HIC3 Description | CALCIUM CHANNEL BLOCKING AGENTS |
GCN | 47984 |
HICL Sequence Number | 000184 |
HICL Sequence Number Description | NIMODIPINE |
Brand/Generic | Brand |
Proprietary Name | Nymalize |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | nimodipine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION |
Route | ORAL |
Active Ingredient Strength | 30 |
Active Ingredient Units | mg/5mL |
Substance Name | NIMODIPINE |
Labeler Name | Azurity Pharmaceuticals, Inc. |
Pharmaceutical Class | Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA203340 |
Listing Certified Through | 2024-12-31 |
Package
NDC 24338-0230-12 (24338023012)
NDC Package Code | 24338-230-12 |
---|---|
Billing NDC | 24338023012 |
Package | 12 PACKAGE in 1 CARTON (24338-230-12) / 1 SYRINGE, PLASTIC in 1 PACKAGE (24338-230-05) / 5 mL in 1 SYRINGE, PLASTIC |
Marketing Start Date | 2020-05-04 |
NDC Exclude Flag | N |
Pricing Information | N/A |